Skip to content

A Study on the Effectiveness of Cognitive Function Training Software in Alleviating Postoperative Cognitive Impairment Symptoms in Patients with Intracranial Tumors: A Prospective, Single-Center, Randomized, Single-Blind, Controlled Trial.

A Study on the Effectiveness of Cognitive Function Training Software in Alleviating Postoperative Cognitive Impairment Symptoms in Patients with Intracranial Tumors: A Prospective, Single-Center, Randomized, Single-Blind, Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128136
Enrollment
Unknown
Registered
2026-07-14
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Impairment after Intracranial Tumor Surgery

Interventions

Intervention group:Use Tencent cognitive training software and receive health education and lifestyle guidance.
Control group.:Receive health education and lifestyle guidance.

Sponsors

The First Affiliated Hospital,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed intracranial tumor, with cognitive dysfunction occurring after craniotomy. 2. Age at enrollment >=18 and =16 weeks. 4. Karnofsky Performance Status (KPS) score >=70. 5. Able to use a smartphone with internet access, expected to independently complete the game-based training, and likely able to pass the first level of the game. 6. Baseline assessment indicates cognitive impairment: postoperative patients with a Montreal Cognitive Assessment (MoCA, Beijing version) score =4 days per week and >=4 hours per day, and is willing to accompany the subject to study visits. 8. The subject and/or their legal guardian can understand the purpose of the study, demonstrate adequate compliance with the study protocol, and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Currently taking psychotropic medications or having other conditions that are expected to prevent completion of device operation. 2. The investigator judges the subject’s condition to be unstable. 3. Patients with blindness or deafness, or those with Alzheimer’s disease. 4. Concurrent participation in another clinical study, unless it is an observational, non-interventional study. 5. Known history of psychiatric disorders, substance abuse, alcoholism, or drug use. 6. Pregnant or breastfeeding women. 7. Any other conditions in which the investigator, in consideration of the subject’s best interests, determines that the subject should not participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Loewenstein Occupational Therapy Cognitive Assessment (LOTCA);

Secondary

MeasureTime frame
Montreal Cognitive Assessment (MoCA), Beijing version;Beijing version, and the European Organisation for Research and Treatment of Cancer Quality of Life;

Countries

China

Contacts

Public ContactXuesong Liu

The First Affiliated Hospital,Sun Yat-sen University

xuesongliu98@163.com+86 20 2227 0619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026